Although this study was limited to patients with a diagnosis of SLE, the results also suggest some protective effect of hydroxychloroquine in the treatment of preterm labor, considering that 40% of SLE patients have anti-SSA/RO antibodies [3]. The gene discussed is CALR; the disease is systemic lupus erythematosus.